Negev Capital
Finance · United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.negevcap.comRevenue
$5.6 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Negev Capital
Negev Capital is a Psychedelic Medical Intervention Investment Fund focused on investing in early-stage companies developing psychedelic medicines for psychiatric conditions. With a fund size of over $30 million, they target investments in the USA, Canada, EU, and Israel, providing capital ranging from $500K to $2M per deal. Their portfolio includes companies like Mindset Pharma and Beckley Psytech, which are dedicated to addressing mental health issues through innovative therapeutic solutions. Negev Capital aims to support its portfolio companies not only with funding but also with strategic advice and industry expertise.Explore more
Negev Capital Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Negev Capital your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Click to see if Negev Capital had a recent Job posting/layoffs
Check if Negev Capital has recently received funding, and reach out quickly before it becomes old news!
Check out if Negev Capital is spiking on competitors!
Funding: Get notified immidiatlly once Negev Capital has new funding data
Product Launch: Get notified when Negev Capital launches new products
Earning: See what the market has to say on Negev Capital recently announced quarterly report
Negev Capital, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Negev Capital
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Negev Capital
Compare insights from companies similar to Negev Capital, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Negev Capital is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Negev Capital is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Negev Capital.
Negev Capital Tech Stack
A closer look at the technologies used by Negev Capital
Negev Capital News & Media
Negev Capital Announces Final Close of $30M+ for Fund One, Set to Back Psychedelic Drug Development Startups
Negev Capital is an early stage VC fund. Negev Capital invests in companies that develop novel drugs for neuropsychiatric disorders, based on psychedelic compounds. 40% of total capital has been deployed into 20 companies.Toronto, Ontario--(Newsfile Corp. - January 17, 2022) - Negev Capital, a psychedelic medical intervention investment fund, today announced the final close of its investment vehicle, "Fund One" at US$30 million of fully contributed capital, thanks to the strong support from Nege
Read more news
Top Finance Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Negev Capital
Sign Up For FreeTo access detailed company insights
Negev Capital is a Psychedelic Medical Intervention Investment Fund focused on investing in early-stage companies developing psychedelic medicines for psychiatric conditions. With a fund size of over $30 million, they target investments in the USA, Canada, EU, and Israel, providing capital ranging from $500K to $2M per deal. Their portfolio include... Read More
